Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LYRA
3751
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $2.9M | ﹤0.01% |
+5,116
| New | +$3.74M |
|
3752
Algonquin Power & Utilities
AQN
$4.53B
| $2.9M | ﹤0.01% |
+224,544
| New | +$3.07M |
|
|
MSGN
3753
DELISTED
MSG Networks Inc.
MSGN
| $2.9M | ﹤0.01% |
291,408
-59,019
| -17% | -$674K |
|
|
AMTD
3754
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.9M | ﹤0.01% |
79,671
+24,079
| +43% | +$906K |
|
3755
CALL
AppFolio
APPF
$7.23B
| $2.9M | ﹤0.01% |
17,800
+10,800
| +154% | +$1.41M |
|
3756
Monarch Casino & Resort
MCRI
$2.22B
| $2.9M | ﹤0.01% |
84,922
+13,110
| +18% | +$434K |
|
3757
CALL
Kinsale Capital Group
KNSL
$8.64B
| $2.89M | ﹤0.01% |
18,600
+2,700
| +17% | +$360K |
|
3758
John B. Sanfilippo & Son
JBSS
$1.01B
| $2.88M | ﹤0.01% |
33,769
-20,553
| -38% | -$1.74M |
|
|
VBIV
3759
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $2.88M | ﹤0.01% |
30,970
+30,370
| +5,062% | +$1.67M |
|
3760
PUT
Eldorado Gold
EGO
$10.4B
| $2.88M | ﹤0.01% |
296,700
+194,800
| +191% | +$1.69M |
|
3761
PUT
Murphy Oil
MUR
$4.96B
| $2.88M | ﹤0.01% |
208,500
+114,700
| +122% | +$1.32M |
|
3762
Vanguard Industrials ETF
VIS
$8.54B
| $2.88M | ﹤0.01% |
22,143
-52
| -0.2% | -$6.35K |
|
3763
Ryman Hospitality Properties
RHP
$7.92B
| $2.88M | ﹤0.01% |
83,110
-213,517
| -72% | -$7.09M |
|
3764
CALL
Varonis Systems
VRNS
$5.17B
| $2.88M | ﹤0.01% |
97,500
-29,100
| -23% | -$728K |
|
3765
CALL
HealthEquity
HQY
$8.76B
| $2.88M | ﹤0.01% |
49,000
-5,600
| -10% | -$310K |
|
|
HA
3766
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.88M | ﹤0.01% |
+204,718
| New | +$2.79M |
|
3767
ING
ING
$102B
| $2.87M | ﹤0.01% |
416,402
+137,115
| +49% | +$832K |
|
3768
PUT
TD Synnex
SNX
$20.7B
| $2.87M | ﹤0.01% |
48,000
+17,400
| +57% | +$813K |
|
3769
Howard Hughes
HHH
$3.98B
| $2.87M | ﹤0.01% |
57,957
-22,699
| -28% | -$1.14M |
|
3770
FlexShares Quality Dividend Index Fund
QDF
$2.28B
| $2.87M | ﹤0.01% |
67,884
-61,208
| -47% | -$2.48M |
|
3771
CALL
PetMed Express
PETS
$39.6M
| $2.87M | ﹤0.01% |
80,400
+55,700
| +226% | +$1.93M |
|
3772
Anterix
ATEX
$1.79B
| $2.86M | ﹤0.01% |
63,106
+18,313
| +41% | +$936K |
|
3773
Cars.com
CARS
$663M
| $2.86M | ﹤0.01% |
496,811
+118,544
| +31% | +$655K |
|
3774
Idexx Laboratories
IDXX
$43.4B
| $2.86M | ﹤0.01% |
8,661
+4,930
| +132% | +$1.43M |
|
|
ARNA
3775
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.86M | ﹤0.01% |
45,400
-4,700
| -9% | -$259K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.